Cargando…

EC330, a small-molecule compound, is a potential novel inhibitor of LIF signaling

Detalles Bibliográficos
Autores principales:	Yue, Xuetian, Wu, Fangnan, Wang, Jianming, Kim, Kaitlin, Santhamma, Bindu, Dileep, Kalarickal V, Zhang, Kam Y J, Viswanadhapalli, Suryavathi, Vadlamudi, Ratna K, Ahmed, Gulzar, Feng, Zhaohui, Nickisch, Klaus, Hu, Wenwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7333478/ https://www.ncbi.nlm.nih.gov/pubmed/32221559 http://dx.doi.org/10.1093/jmcb/mjaa008

Ejemplares similares

Targeting LIF/LIFR signaling in cancer
por: Viswanadhapalli, Suryavathi, et al.
Publicado: (2021)

EC313-a tissue selective SPRM reduces the growth and proliferation of uterine fibroids in a human uterine fibroid tissue xenograft model
por: Nair, Hareesh B., et al.
Publicado: (2019)

LIF/LIFR oncogenic signaling is a novel therapeutic target in endometrial cancer
por: Tang, Weiwei, et al.
Publicado: (2021)

The LIFR-targeting small molecules EC330/EC359 are potent ferroptosis inducers
por: Feng, Chang-Zhou, et al.
Publicado: (2022)

Effects of Combination of Estradiol with Selective Progesterone Receptor Modulators (SPRMs) on Human Breast Cancer Cells In Vitro and In Vivo
por: Nair, Hareesh B., et al.
Publicado: (2016)

LIF promotes tumorigenesis and metastasis of breast cancer through the AKT-mTOR pathway
por: Li, Xiaoyan, et al.
Publicado: (2014)

LIFR inhibition enhances the therapeutic efficacy of HDAC inhibitors in triple negative breast cancer
por: Li, Mengxing, et al.
Publicado: (2021)

Utilizing cell line-derived organoids to evaluate the efficacy of a novel LIFR-inhibitor, EC359 in targeting pancreatic tumor stroma
por: Hall, Bradley R., et al.
Publicado: (2019)

HIF-2α mediates hypoxia-induced LIF expression in human colorectal cancer cells
por: Wu, Lihua, et al.
Publicado: (2015)

Inhibition of LIFR Blocks Adiposity-Driven Endometrioid Endometrial Cancer Growth
por: Blankenship, Logan, et al.
Publicado: (2022)

Global Genomic and Proteomic Analysis Identified Critical Pathways Modulated by Proto-Oncogene PELP1 in TNBC
por: Liu, Zexuan, et al.
Publicado: (2022)

Targeting PELP1 oncogenic signaling in TNBC with the small molecule inhibitor SMIP34
por: Altwegg, Kristin A., et al.
Publicado: (2023)

LIF is essential for ISC function and protects against radiation-induced gastrointestinal syndrome
por: Wang, Huaying, et al.
Publicado: (2020)

Estrogen receptor beta enhances chemotherapy response of GBM cells by down regulating DNA damage response pathways
por: Zhou, Mei, et al.
Publicado: (2019)

LIF negatively regulates tumor suppressor p53 through Stat3/ID1/MDM2 in colorectal cancers
por: Yu, Haiyang, et al.
Publicado: (2014)

Esters of levonorgestrel and etonogestrel intended as single, subcutaneous-injection, long-lasting contraceptives
por: Meece, Frederick A., et al.
Publicado: (2018)

The antidepressant imipramine inhibits breast cancer growth by targeting estrogen receptor signaling and DNA repair events
por: Timilsina, Santosh, et al.
Publicado: (2022)

Therapeutic utility of natural estrogen receptor beta agonists on ovarian cancer
por: Liu, Jinyou, et al.
Publicado: (2017)

Interaction of transcription factor AP‐2 gamma with proto‐oncogene PELP1 promotes tumorigenesis by enhancing RET signaling
por: Liu, Junhao, et al.
Publicado: (2021)

Selective Estrogen Receptor β Agonist LY500307 as a Novel Therapeutic Agent for Glioblastoma
por: Sareddy, Gangadhara R., et al.
Publicado: (2016)

PELP1 promotes glioblastoma progression by enhancing Wnt/β-catenin signaling
por: Sareddy, Gangadhara R, et al.
Publicado: (2019)

330 grabados originales
por: Manilla, Manuel
Publicado: (1971)

Histone deacetylase inhibitors enhance estrogen receptor beta expression and augment agonist-mediated tumor suppression in glioblastoma
por: Pratap, Uday P, et al.
Publicado: (2021)

SETDB1 interactions with PELP1 contributes to breast cancer endocrine therapy resistance
por: Liu, Zexuan, et al.
Publicado: (2022)

Multiple Sclerosis and the LIF/IL-6 Axis: Use of Nanotechnology to Harness the Tolerogenic and Reparative Properties of LIF
por: Metcalfe, Su M., et al.
Publicado: (2015)

Health Tract No. 330: The Guillotine
Publicado: (1868)

Novel focused OCT-LIF endoscope
por: Wall, R. Andrew, et al.
Publicado: (2011)

LIF-STAT signaling and trophoblast biology
por: Suman, Pankaj, et al.
Publicado: (2013)

Beyond LIF Neurons on Neuromorphic Hardware
por: Ward, Mollie, et al.
Publicado: (2022)

A polymorphism in the tumor suppressor p53 affects aging and longevity in mouse models
por: Zhao, Yuhan, et al.
Publicado: (2018)

LIF-Dependent Signaling: New Pieces in the Lego
por: Mathieu, Marie-Emmanuelle, et al.
Publicado: (2011)

LIF signal in mouse embryonic stem cells
por: Ohtsuka, Satoshi, et al.
Publicado: (2015)

Junctional Adhesion Molecule 2 Mediates the Interaction between Hatched Blastocyst and Luminal Epithelium: Induction by Progesterone and LIF
por: Su, Ren-Wei, et al.
Publicado: (2012)

A novel mutant p53 binding partner BAG5 stabilizes mutant p53 and promotes mutant p53 GOFs in tumorigenesis
por: Yue, Xuetian, et al.
Publicado: (2016)

LIF and the lung’s stem cell niche: is failure to use LIF to protect against COVID-19 a grave omission in managing the pandemic?
por: Metcalfe, Su M
Publicado: (2020)

Pompe turbomoleculaire TSU 330 L/s balzers
por: Versolatto, B
Publicado: (1988)

Estrogen receptor coregulator binding modulators (ERXs) effectively target estrogen receptor positive human breast cancers
por: Raj, Ganesh V, et al.
Publicado: (2017)

Kinetic characterisation of LiF: Cu$^{2+}$ thermoluminescence
por: Leroy, C, et al.
Publicado: (1996)

Measurement of the supralinearity of $^{7}$LiF thermoluminescent dosimeters
por: Hancock, I B
Publicado: (1978)

Calcium current improves coincidence detection of the LIF model
por: Chua, Yansong, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_bbtv0odchenk2u7rraufg6j912